Pharmacologic management of sexually transmitted diseases

Journal of Nurse-Midwifery

Volumn 42, Issue 3, 1997, Pages 275-289

  Roe, Valerie A ^a   Gudi, Anne ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SEXUALLY TRANSMITTED DISEASE; VAGINA CANDIDIASIS; VAGINA DISEASE;

CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; VAGINAL DISEASES;

EID: 0031136040     PISSN: 00912182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-2182(97)00030-X     Document Type: Article

References (110)

1. Swanson JM, Chenitz WC. Regaining a valued self: the process of adaptation to living with genital herpes. Qual Health Res 1993;3:270-97.
2. Koehn KA, Burnette MM, Stark C. Applied relaxation training in the treatment of genital herpes. J Behav Ther Exp Psychol 1993;24:331-41.
3. Clark JL, Teatime NO. Management of genital herpes. Am Fam Phys 1995;51:175-82.
4. Corey L. The current trend in genital herpes: progress in prevention. Sex Trans Dis 1994;118:414-8.
5. Kinghorn GR. Genital herpes: natural history and treatment of acute episodes. J Med Virol 1993; Suppl 1:33-8.
6. McKendall RR. Herpes simplex virus diseases. In: McKendall RR, Stroop WG, editors. Handbook of neurovirology. New York: Marcel Dekker, 1994:253-67.
7. de Ruiter A, Thin RN. Genital herpes: a guide to pharmacological therapy. Drugs 1994;47:297-304.
8. Corey L. Herpes simplex virus infections during the decade since licensure of acyclovir. J Med Virol 1993; Suppl 1:7-12.
9. Elion GB. Acyclovir: discovery, mechanism of action, and selectivity. J Med Virol 1993; Suppl 1:2-6.
10. Elion GB. The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother 1983;12: Suppl B:9-17.
11. Whitley R. Antiviral therapy: the time has come. J Med Virol 1993;1 Suppl B:2.
12. Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. JAMA 1992;327:782-87.
13. Mindel A, Sutherland S. Genital herpes: the disease and its treatment including intravenous acyclovir. J Antimicrob Chemother 1983; 12 Suppl B:51-9.
14. Bryson Y. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus. J Antimicrob Chemother 1983;12 Suppl B:61-9.
15. Reichman R, Bodger GJ. Mertz GJ, Corey L, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. JAMA 1984;251:2103-7.
16. Mindel A. Long-term clinical and psycological management of genital herpes. J Med Virol 1993; Suppl 1:39-44.
17. Goldberg LH, Kaufman RH, Kurtz TO, et al. Continuous fiveyear treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovir. J Med Virol 1993;1:45-50.
18. Corey L, Benedetti J, Critchiow C, et al. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983; 12 Suppl B:79-88.
19. Fiddian AP, Kinghorn GR, Goldmeier D, Rees E, Rodin P, Thin NT. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. J Antimicrob Chemother 1983; 12 Suppl B:67-77.
20. Tilson HH, Engle CR, Andrews EB. Safety of acyclovir: a summary of the first 10 years of experience. J Med Virol 1993; Suppl 1:67-73.
21. de Miranda P, Blum R. Pharmacokinetics of acyclovir, after intravenous and oral administration. J Antimicrob Chemother 1983; 12 Suppl B:29-37.
22. Andrews EB, Yankaskas BC, Cordero JF, et al. Acyclovir in pregnancy registry: six years experience. Obstet Gynecol 1992;79:7-13.
23. Haddad J, Langer B, Astruc D, Messes J, Lokiec F. Oral acyclovir and recurrent genital herpes during late pregnancy. Obstet Gynecol 1993;82:102-4.
24. Griffiths PD. Future management of herpesvirus infections. J Med Virol 1993; Suppl 1:165-68.
25. Jamison JH, Kaplan DW, Hamman R, Eagan R, Beach R, Douglas JM Jr. Spectrum of genital HPV infection in a female adolescent population. Sex Trans Dis 1995;22 No 4:236-43.
26. Stone KM. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995:20 Suppl 1:591-597.
27. Reid R, Greenberg M. Jenson B, et al. Sexually transmitted papilloma infections: the anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol 1987;156:212-22.
28. Kraus SJ, Stone KM. Management of genital infection caused by human papillomavirus. Rev Infect Dis 1990;12 Suppl 6:s620-32.
29. Greenberg MD, Rutledge LH, Reid R, et al. A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol 1991;77:735-9.
30. Rockley PF, Tyring SK. Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections. Pharmacol Ther 1995;65:265-87.
31. Physicians Gen Rx 1996. Mosby's Complete Drug Reference. St. Louis (MO), 1996.
32. Didcock K, Jackson D, Robson JM. The action of some nucleotoxic substances on pregnancy. Br J Pharmacol 1956;11:437-41.
33. Cirelli R, Tyring SK. Interferons in HPV. Antiviral Res 1994;24 No 2-3:191-204.
34. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. CDC, 1993.
35. Mines J, Shin-je G, Schlegel R, Bennett JA. Prospects for a vaccine against human papillomavirus. Obstet Gynecol 1995;86:860-6.
36. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis, and the "healthy" HBsAg earner state. Hepatology 1987; 7:4758-63.
37. Frymoyer LC. Preventing the spread of viral hepatitis. Am Fam Physl993;48:1479-86.
38. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20:992-1000.
39. Boehme TL. Hepatitis B: the nurse-midife's role in management and prevention. J Nurse Midwifery 1985;30:79-87.
40. Merck & Co. Recombivax HB. Package insert, 1986.
41. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood. MMWR 1995;44:929-33.
42. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and administration of zidovudine in health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913-9.
43. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
44. Puro V, Ippolito G, Gussanti E. Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. AIDS 1992;6: 963-9.
45. New York State Department of Health. Clinical guidelines for the use of zidovudine therapy in pregnancy to reduce perinatal transmission of HIV. NYSDH, October 1994.
46. Rolfs RT. Treatment of syphilis, 1993. Clin Infect Dis 1995;20 Suppl 1:523-38.
47. Schroeter AL, Lucas JB, Price EV, Falcone VH. Treatment for early syphilis and reactivity of serologic tests. JAMA 1972;221: 471-6.
48. Star W, Lommel L, Shonnon M. Sexually transmitted diseases. Woman's Primary Health Care: Protocols for Practice. American Nurses Publishing: Washington (DC): 1995.
49. Weinstock H. Dean D, Bolan G. Chlamydia trachomatis infections. Infect Dis Clin North Am 1994;8:797-812.
50. Skolnick N. Screening for chlamydia trachomatis infection. Am Fam Phys 1994;51:821-24.
51. Silverman N, Sullivan M, Hochman M, Womach M, Gungkind D. A randomized trial comparing amoxicillin and erthyomycin for treatment of chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 1994;70:829-34.
52. Crombleholme WR. Schachter J, Grossman M, Landers D, Sweet RL. Amoxicillin therapy for chlamydia trachomatis in pregnancy. Obstet Gynecol 1990;(75):752-6.
53. Alary M, Joey J, Mountquin J. Randomized comparison of amoxycillin and erythromycin therapy in treatment of genital chlamydial infection in pregnancy. Lancet 1994;344:1461-5.
54. Magat A, Alger L, Nagey D, Hatch V, Lovchik J. Double blind randomized study comparing amoxicillin and erthyromycin for treatment of chlamydial trachomatis in pregnancy. Obstet Gynecol 1993;81 (Ft l):745-9.
55. Turnentine M, Newton E. Amoxicillin or erythomycin for the treatment of chlamydial infection: a meta-analysis. Obstet Gynecol 1995;86:1021-5.
56. Alger LS, Lovchick J. Comparative efficacy of clindamycin in eradication of antenatal chlamydia trachomatis. Am J Obstet Gynecol 1991;165:375-81.
57. Stamm WE. Azithromycin in the treatment of uncomplicated genital chlamydial infections. AJM 1995.
58. Weber J, Johnson E. New treatment for chlamydia trachomatis genital infections. Clin Infect Dis 1995;20 Suppl 1:66-71.
59. Bush M, Rosa C. Azithromycin and erythromycin in the treatment of cervical chlamydial infections during pregnancy. Obstet Gynecol 1994;84:61-3.
60. Hammerschlag MR, Golden NH, Oh MK, Gilling M. Single dose azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1995;122:961-5.
61. Magid D, Douglas JM, Schwartz J. Doxycycline compared with azithromycin for treating women with genital chlamydia trachomatis infections: an incremental cost effectiveness analysis. Ann Intern Med 1996;124:389-99.
62. Faro S, Martens M, Maccato M, Hammel H, Roberts S, Riddle G. Effectiveness of ofloxacin in the treatment chlamydia trachomatic and neisseria gonorrhea cervical infections. Am J Obstet Gynecol 1991;164:1380-3.
63. Morgabag W, Holmes B, Murry M, Beville R, Lutz F. Randomized comparison of ofloxacin and doxycycline for chlamydia urethritis and cervicitis. Chemotherapy 1990:36:70-6.
64. Martens M, Gordon S, Yarborough D, Faro S, Binder D, Berkeley A. Multicenter randomized trial of ofloxacin versus cefixime and doxycycline in outpatient treatment of PID. Southern Med J 1993;86:604-10.
65. Moran J, Levine W. Drugs of choice for treatment of uncomplicated gonoccocal infections. Clin Infect Dis 1995;201:47-65.
66. Hook EW III, Jones RB, Martin DH, et al. Comparison of ciprofloxacin and ceftriaxone as single dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother 1993:37:1670-3.
67. Sherrard JS, Bingham JS. Gonorrhea now. Int J STD AIDS 1995;6:162-6.
68. Hawley HB. Gonorrhea: finding and treating a moveable target. Post Grad Med 1993:94:105-11.
69. Mogabgab W, Luts FB. Randomized study of cefixime versus ceftriaxone for uncomplicated gonorrhea. South Med J 1994;87: 461-4.
70. Echols R, Heyd A, O'Keeffe B, Schact P. Single dose ciprofloxacin in the treatment of uncomplicated gonorrhea: a world wide summary. Sex Trans Dis 1994;20:345-51.
71. Flouroqinolone resistance in Neisseria gonorrhea: Colorado and Washington 1995. MMWR 1995;44:761-4.
72. Kaufman RH. Faro S. Benign diseases of the vulva and vagina. 4th ed. St. Louis: Mosby Co., 1994.
73. Heine P, McGregor JA. Trichomonas vaginalis: a re-emerging pathogen. Clin Obstet Gynecol 1993:36:137-44.
74. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of vaginal flora in pregnancy. Am J Obstet Gynecol 1984:150:965-72.
75. Schwebke J. Metronidazole: utilization in the obstetric and gynecological patient. Sex Trans Dis 1995;22:370-5.
76. Tidwell B, Lushbaugh WB, Laughlin M, Cleary J, Finley R. A double blind placebo controlled trial of single dose intravaginal versus single dose oral metronidazole in the treatment of trichomonal vaginitis. J Infect Dis 1994; 170:242-6.
77. Physician Desk Reference. 50th ed. Montvale Medical Economics, 1996.
78. Murphy P, Jones E. Use of oral metronidazole in pregnancy. J Nurse Midwife 1994;39:214-9.
79. Ried B, Ejler A. Vaginal infections: diagnosis and management. Am Fam Phys 1993;47:1805-16.
80. Upjohn & Co. Bacterial vaginosis: new perspectives. Upjohn & Co., 1993.
81. Millier S. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;163:455-9.
82. Sweet R, Gibbs R. Infectious diseases of the female genital tract. 2nd ed. Baltimore: Williams & Wilkins, 1990.
83. Amsel R, Torten P, Speigal C, Chen K, Eschenback D. Non-specific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am J Med 1983;74:14-22.
84. Soper D, Bump R, Hurt W. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990; 163:1016-23.
85. Soper D. Bacterial vaginosis and postoperative infections. Am J Obstet Gynecol 1993; 169:467-9.
86. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1995;20Suppl 1:72-9.
87. Eschenbach D. Bacterial vaginosis: emphasis in upper genital tract complications. Obstet Gynecol Clin North Am 1989; 16:593-610.
88. Martius J, Eschenbach D. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity: a review. Arch Gynecol Obstet 1990;247:1-13.
89. Hay P, Lamont R, Taylor-Robinson P, Morgan D. Abnormal bactrial conlonization of the genital tract and subsequent preterm delivery and late miscarriage. Br J Med 1994;308:295-8.
90. Thomason JL, Gelbart S, Scaglione N. Bacterial vaginosis: current review with indications for asymptomatic therapy. Am J Obstet Gynecol 1991;165:210-7.
91. Gibbs R. Chorioamnionitis and bacterial vaginosis. Am J Obstet Gynecol 1993, 169:460-3.
92. Goode M, Grauer K, Gums J. Infectious vaginitis: selecting therapy and preventing recurrence. Post Grad Med 1994;96:85-98.
93. Andes F, Parker R, Hosein I. Clindamycin vaginal cream versus oral metronizadole in the treatment of bacterial vaginosis: a prospective clinical trial. Southern Med J 1992;85:1077-80.
94. Fishback F, Peterson E, Weissenbacher E, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metron-idazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993:82:405-10.
95. Hill G, Livengood C. Bacterial vaginosis associated microflora and effects of topical intravaginal clindamycin. Am J Obstet Gynecol 1994:171:1198-04.
96. Hillier S, Lipinski C, Briseldea A, Eschenbach D. Efficacy of intravaginal 0.75% metronidazole gel for treatment of baterial vaginosis. Obstet Gynecol 1993:81:963-7.
97. Lugo-Miro V, Green M, Maguire L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. JAMA 1992:268:92-5.
98. Schmidt C, Sobel J, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-3.
99. Hillier S, Krohn M, Watts D, Wolner-Hanssen P, Eisenbach D. Microbiologie effiacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
100. Livengood C, McGregor J, Sopr D, Newton E, Thomason J. Baterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol 1994; 170:759-64.
101. Ferns DG, Litaker MS, Woodward L, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel and clindamycin vaginal cream. J Fam Pract 1995:41:443-9.
102. McCormack W, Starko KM, Zinver SH. Symptoms associated with vaginal colonization with yeast. Am J Obstet Gynecol 1988;158:31-3.
103. Nyirjesy P, Seeney SM, Terry Grody MT, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 1995:173:820-3.
104. Eschenbach DA, Hillier SL. Advances in diagnostic testing for vaginitis and cervicitis. J Reprod Med 1989;34 Suppl:555-63.
105. Horowitz BJ, Graquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992;32:248-55.
106. Sobel J. Individualizing treatment of vaginal candidiasis. J Am Acad Dermatol 1990;23:572-6.
107. Ross R, Lee MT, Onderdonk AB. Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol 1995;86:925-9.
108. Reed SE, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis. Clin Infect Dis 1995;20 Suppl 1:580-90.
109. Sobel JD, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol 1995:172:1263-7.
110. Hilton H, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yogurt containing lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992:116:353-7.